
Tevogen Bio Reports Nasdaq Listing Compliance as CEO Reaffirms His Commitment in Bridging the Information Gap About the Company
WARREN, N.J., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf, gen...

The Gap: Looking For A Turnaround Continuation In Q3 (Rating Upgrade)
The Gap, Inc.'s Q3 report is important as the company needs to show continued progress in the recently successful brand turnaround. A weak consumer weighs on the Q3 outlook, causing a more moderate...

Is The Gap (GAP) a Great Value Stock Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the lat...

Gap Stock Rises 9% in a Month: Should You Buy Now or Wait?
GAP is well-positioned for long-term growth, supported by its strategic focus on improving brands and maintaining financial and operational rigor.

New Economic Report Finds Total Quantified Value of a Terrestrial GPS Backup is $14.6 Billion
NextNav's Next-Generation 3D Terrestrial PNT Solution in Lower 900 MHz Band has Potential to Save US Economy $663 Million for One Day of a Global GPS Outage NextNav's Next-Generation 3D Terrestrial...

SELLAS Announces U.S. FDA Rare Pediatric Disease Designation (RPDD) Granted to Galinpepimut-S (GPS) for the Treatment of Pediatric Acute Myeloid Le...
- GPS Currently Investigated in Phase 3 REGAL Trial in Adult AML Patients – Interim Analysis Anticipated in Q4 2024 - - RPDD Provides Eligibility for GPS to Receive a Priority Review Voucher (PRV) ...

Tiger Brokers' Yang Xu Shares Insights on Bitcoin ETFs Bridging the Gap Between Traditional Finance and Digital Assets
HONG KONG , Oct. 8, 2024 /PRNewswire/ -- Yang Xu, Global Partner at leading global online brokerage Tiger Brokers, shared insights on how Bitcoin Exchange-Traded Funds (ETFs) are shaping the tradit...

Value Gap Is Closing For New York Community Bank
NYCB's price still sits at a deep discount to its balance sheet, and due diligence by new management of its loans has raised confidence. The turnaround story focuses on reducing noninterest expense...

The Gap: Rated Buy As I Expect Growth And Margins To Normalize
I give a buy rating for GAP, expecting sustained growth momentum and expanding earnings margins, driving valuation multiples higher. GAP's strong 2Q24 performance, driven by 3% comparable sales gro...

Gap's Brand Turnaround in Motion as Lululemon Hits New Highs in Global Sales
As the retail sector faces a complex mix of opportunities and challenges, Gap and Lululemon are charting distinct courses in their recent earnings reports. While Gap focuses on revitalizing its cor...

Gap raises forecasts after a bumper quarter
Gap Inc (NYSE:GPS) exceeded sales expectations in the second quarter and upgraded forecasts, signalling that changes implemented by new CEO Richard Dickson hitting the mark. For the quarter ending ...

Gap Posts Strong Quarterly Results With Early Release Leading to Trading Halt
Gap (GAP) posted better-than-expected results for the second quarter and boosted its guidance on higher sales at its Gap and Old Navy stores.

Gap (GAP) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
The headline numbers for Gap (GAP) give insight into how the company performed in the quarter ended July 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates a...

Will Gap (GAP) Beat Estimates Again in Its Next Earnings Report?
Gap (GAP) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Gap (GPS) Jumps 11% in a Month: Is it an Ideal Time to Buy?
Gap's (GPS) focus on reinforcing its brand relevance and expanding market share through marketing and innovation bolsters its performance.
Related Companies